Life Sciences: Transactional 2019

Our research into the global life sciences transactional legal market sees 208 lawyers highlighted for their work in the field.

Methodology

The Global Elite Thought Leaders are those individuals who received the highest number of nominations from peers, corporate counsel and other market sources this year. Our research has identified them as truly outstanding practitioners and the very best in their field.
 
Who's Who Legal does not list law firms, only individual lawyers. The leading firms are those in each region whose listed practitioners received the most total nominations in our research.
 

EMEA

Global Elite Thought Leaders
1. Stefano Codoni  Walder Wyss Ltd, Lugano
2. Patrick Duxbury  Gowling WLG, Birmingham
3. Malcolm Bates  Taylor Wessing LLP, Cambridge
4. Yuval Horn  Horn & Co Law Offices, Tel Aviv
5. Laura Anderson  Bristows LLP, London

Leading Firms

Covington & Burling

This international powerhouse sees five individuals highlighted from its offices in the region.
James Gubbins is a prominent figure in the space with respondents to our research lauding his vast experience on IPOs and private equity transactions.
Lucinda Osborne has a stellar reputation in the market for her skill on an array of transactional matters, including strategic collaborations and product transfers in the life sciences space.
James Halstead wins plaudits from across the region for his superb handling of M&A and IPOs for international pharmaceutical and other life sciences companies, including Johnson & Johnson.
Daniel Pavin is an impressive practitioner who is frequently engaged in complex IP-related transactional matters in the sector, including licensing, collaboration and partnering arrangements.
Paul Claydon is well known for his expertise on transactions involving private equity and venture capital, especially for clients in the biotechnology and pharmaceutical sectors.

Taylor Wessing

This firm stands out for the quality of its practitioners, with three leading names highlighted in this year’s guide.
Malcolm Bates is one of the pre-eminent individuals in our research and is highlighted as a Global Elite Thought Leader this year. UK-based peers are unanimous in their praise of his practice, which features in-depth understanding of distribution, collaboration and outsourcing transactions.
Tim Worden possesses “strong expertise” and a superb practice in this area. He is notable for his wide-ranging insight into licensing agreements in the biotech, medical device and pharmaceutical sectors.
David Mardle is an outstanding transactional lawyer who wins effusive praise from interviewees for his work on behalf of technology and life sciences clients.

Cooley

Cooley continues to impress in our research, with three much-applauded individuals included.
John Wilkinson is “a diligent lawyer” who possesses “great interpersonal skills” according to impressed clients. He excels on matters such as joint ventures and also has deep experience in co-marketing arrangements.
Nicola Maguire is lauded by sources for her “attention to detail” and “understanding of the biotechnology and pharmaceutical industries”. Considered “great to work with”, she provides “pragmatic, commercial advice”.
Stephen Rosen is endorsed by peers for his top-class ability on corporate matters, including venture capital financings and M&A transactions in the field.

Other Leading Individuals

England

Gowling’s Patrick Duxbury is a go-to name in the market and one of the top practitioners in the UK, as reflected by his selection as a Global Elite Thought Leader in our research. He offers stellar understanding and experience of transactions in the pharmaceutical and biotechnology sectors.

At Bristows, Laura Anderson has “a very deep understanding of the University Technology Transfer space”, report interviewees. Clients laud her “expert negotiation skills and style”, stating that she is “an expert in all aspects of what she does and is a delight to work with”.

Israel

Yuval Horn of Horn & Co Law Offices is a “highly competent lawyer with significant experience in the life sciences sector”, according to sources. He is a leading name in the region with a distinguished practice that sees him involved in a range of licensing, joint venture and M&A transactions.

Sweden

Advokatfirman Delphi’s Per Lagerkvist is “very well versed on matters in the life sciences sector” according to our sources. He a leading figure in the Nordics, with fantastic experience on M&A transactions and financing arrangements.
Elisabeth Eklund is a distinguished individual who wins plaudits from across Europe for her superb ability on a range of issues in the life sciences space.

Switzerland

Walder Wyss’ Stefano Codoni is a "well-known lawyer" and Global Elite Thought Leader in the field who is lauded by peers for his "wide-ranging knowledge of the life sciences sector".
Florian Gunz Niedermann is an "exceptionally competent lawyer" who possesses "significant experience in the life sciences sector", including specialist knowledge of venture capital projects.

 

North America

Global Elite Thought Leaders
1. Marc A Rubenstein  Ropes & Gray LLP, Boston
2. Barbara Kosacz  Cooley LLP, Palo Alto
3. John A Hurvitz   Covington & Burling LLP, Washington
4. Kingsley L Taft  Goodwin, Boston
5. Alan C Mendelson  Latham & Watkins LLP, Menlo Park

Leading Firms

Cooley

This firm is a dominant force in the North American market, with 13 practitioners highlighted in this year’s guide.
Barbara Kosacz is “a leading lawyer the transactional space” according to peers, excelling on M&A, financings and strategic partnering arrangements. She is a repeat selection as a Global Elite Thought Leader this year.
Robert Jones is commended by respondents as “the patriarch of the field” and is credited for his “vast experience” on matters such as public and private financings.
The “excellent” Marc Recht has a top-drawer reputation in the region and a “significant life sciences practice” which sees him engaged in securities offerings and M&A across the healthcare sector.
Kay Chandler is “a superb lawyer” according to multiple interviewees across the USA. She is recommended for her deep understanding of technology licenses and acquisitions and supply arrangements.
Kenneth Krisko is a life sciences specialist who wins plaudits from across the region for his fantastic work on matters such as technology acquisitions and research collaborations.
Laura Berezin is a prominent figure at the firm whom respondents to our research applaud as “an excellent securities lawyer”. She possesses over 25 years’ experience working on complex matters in the sector.
Div Gupta is a “great lawyer” and “someone people in the market really know for his work on life sciences corporate finance”, report interviewees.
Jane Adams excels on strategic alliances and technology acquisitions and offers clients wide-ranging experience in the biotechnology and pharmaceutical sectors.

Goodwin

Goodwin’s sees four outstanding lawyers nominated to this year’s guide.
Kingsley Taft is a Global Elite Thought Leader for his exceptional expertise transactional matters in the life sciences field, with respondents stating that he is “very well known for his licensing and collaboration work”.
Michael Bison has a distinguished reputation in the market for his high-quality work on issues including M&A, strategic collaborations and IPOs.
Sarah Solomon garners effusive praise from commentators this year for her excellent practice, which features a wealth of knowledge of partnering transactions and research relationships.
Mitchell Bloom is “one of the best lawyers in Boston” according to market observers, who highlight him as “a leading name at the firm” for issues in the biotechnology, healthcare and medical device sectors.

Ropes & Gray

This firm remains immensely popular in the market, seeing three individuals from their US offices included this year.
“Excellent lawyer” Marc Rubenstein tops our research in North America and therefore gains recognition as a Global Elite Thought Leader. He is highly adept across the transactional space, with notable experience in licence and collaboration agreements and securities offerings.
Patrick O’Brien is a widely recognised figure in the market who stands out for his extensive ability on issues such M&A and IPOs in the pharmaceutical sector.
An outstanding name at the firm, Mark Bellomy draws strong praise from respondents to our research for his impressive handling of technology transfers and joint ventures in the space.

Latham & Watkins

Five excellent practitioners are listed from this excellent West Coast firm’s offices in the US.
Alan Mendelson is variously described as “the grandfather biotech law” and a “legendary name in the field” by peers in the space. He is able to draw on over 45 years of experience handling the gamut of venture capital financings, IPOs and M&A in the sector.
Peter Handrinos “has a very active practice” in life sciences, according to respondents to our research, who state that he is “great in the IPO space”.

Other Leading Individuals

Canada

Fasken’s Jay Lefton has “deep knowledge of corporate law and its application to biotechnology, pharmaceuticals and start-up companies” according to clients who describe him as a “highly responsive, accurate and comprehensive lawyer”.

USA

Covington & Burling’s Global Elite Thought Leader John Hurvitz is “very well known in the market” and “has a great client base”. He is adept on matters such as collaboration arrangements and M&A.

Wiggin and Dana’s James Farrington is “among the most experienced transaction lawyers in the life sciences in the US” according to one impressed peer. He is noted for his Scandinavian-focused work, with sources stating that “he has the market cornered on Swedish biotechs”.

Hogan Lovells is home to a prominent figure in the market in Adam Golden who draws strong support from peers for his superb ability on M&A transactions in the pharmaceutical sector.

 

Latin America

Global Elite Thought Leaders
1. Angela Fan Chi Kung Pinheiro Neto Advogados, São Paulo
2. Gustavo Alcocer  Olivares y Compañía, Mexico City

Leading Individuals

Brazil

Angela Fan Chi Kung of Pinheiro Neto Advogados is a “no-brainer” for inclusion, report interviewees, who call her “the number-one for life sciences transactions in Brazil” and across the region.

Elysangela de Oliveira Rabelo Maurer at TozziniFreire Advogados is “an absolutely fantastic transactional lawyer; one of the best in Brazil”, comments one source. She is widely renowned for her outstanding expertise in the life sciences sector.

Mexico

Gustavo Alcocer of Olivares y Compañía is distinguished individual, lauded as a “very experienced life sciences lawyer” and known for being “well connected” in the jurisdiction.

 

Asia-Pacific

Global Elite Thought Leaders
1. Wee Hann Lim Rajah & Tann Singapore LLP, Singapore
2. Alison Wong Bird & Bird, Hong Kong

Leading Individuals

Australia

Bernard O’Shea at Norton Rose is a leading corporate lawyer in the Australian market with a wealth of knowledge in the life sciences sector, particularly working for pharma and biotech clients.

China

Ropes & Gray’s Arthur Mok is a pre-eminent figure in the region who commands an excellent reputation for his ability on venture capital financings and joint ventures in the biotech and medical device sectors.
Geoffrey Lin receives widespread support from peers this year for his in-depth knowledge of technology transfers in the pharmaceutical and biotechnology sectors.

Hong Kong

At Bird & Bird, Alison Wong continues to earn plaudits for the breadth of her experience on transactional matters, with particular insight into R&D agreements and technology licensing.

Singapore

Rajah & Tann’s Wee Hann Lim is “very active in the market” according to respondents who highlight him in our research this year. He is highly adept at handling cross-border acquisitions and divestments.

Back to top

Follow us on LinkedIn

News & Features

Community News

Analysis

Features

Pro Bono

Corporate Counsel

Women in Law

Future Leaders

Research Reports

Practice Areas

Firms

The Who's Who Legal 100

Awards

Special Reports

Events

Shop

About Us

Research Schedule

It is not possible to buy entry into any Who's Who Legal publication

Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.

Copyright © 2019 Law Business Research Ltd. All rights reserved. | http://www.lbresearch.com

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 20 7908 1180 / Fax: +44 207 229 6910

http://www.whoswholegal.com | editorial@whoswholegal.com

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK